See how science, strategy, and innovation are transforming the GLP-1 space: #GLP1 #oralGLP1 #metabolichealth #diabetescare #obesity #obesitytreatment #pharmainnovation #futureproofingbusinesses #IeB To view or add a comment, sign in #MIMSPharmaMarketInsightUpdate, September 2025 Including: SGLT2 inhibitors should be offered first-line to people with heart failure with reduced ejection fraction A new formulation of Rybelsus (semaglutide) tablets has been released The first inhaled levodopa product, Inbrija (levodopa), has been launched
WeightWatchers includes insurance navigation and clinical support, which can lower costs for covered patients but raises fees for those paying out of pocket
The operation is not intended to be used for weight loss but rather to eliminate localized, disproportionate fat deposits from the body
Weight Management One of the biggest challenges that women face during perimenopause is weight gain, especially around the abdomen area
Instead, his team is interested in how GLP-1s can trigger changes in the way your body produces energy (metabolic pathways) and repairs tissue, which may promote intestinal healing
